Dr. Rand Paul Introduces Amendment to Eliminate Dr. Fauci’s Position as Director of NIAID

By Sen. Rand Paul
Global Research, March 16, 2022
Senator Rand Paul 14 March 2022
Region:
Theme:

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).

To receive Global Research’s Daily Newsletter (selected articles), click here.

Visit and follow us on Instagram at @globalresearch_crg and Twitter at @crglobalization. Feel free to repost and share widely Global Research articles.

***

Today, U.S. Senator and physician Rand Paul (R-KY) introduced an amendment to eliminate Dr. Anthony Fauci’s position as the Director of the National Institute of Allergy and Infectious Diseases (NIAID) and replace it with three separate national research institutes. 

“We’ve learned a lot over the past two years, but one lesson in particular is that no one person should be deemed “dictator-in-chief.” No one person should have unilateral authority to make decisions for millions of Americans,” said Dr. Paul. “To ensure that ineffective, unscientific lockdowns and mandates are never foisted on the American people ever again, I’ve introduced this amendment to eliminate Dr. Anthony Fauci’s position as Director of the National Institute of Allergy and Infectious Diseases, and divide his power into three separate new institutes. This will create accountability and oversight into a taxpayer funded position that has largely abused its power, and has been responsible for many failures and misinformation during the COVID-19 pandemic.”

Background

As recently as 2012, Congress passed a law that eliminated the National Center for Research Resources (NCRR) and reassigned some of its programs to a new National Center for Advancing Translational Sciences (NCATS), and assigned other NCRR functions to other institutes within NIH.

Dr. Paul’s amendment would keep with this precedent of reorganization, and would immediately eliminate Dr. Fauci’s position and replace it with three new directors of the following new institutes:

  1. National Institute of Allergic Diseases
  2. National Institute of Infectious Diseases
  3. National Institute of Immunologic Diseases

Each of these three institutes will be led by a director who is appointed by the president and confirmed by the Senate for a 5-year term.

This amendment also aligns with NIAID’s existing mission statement, which begins by saying:  “NIAID conducts and supports basic and applied research to better understand, treat, and ultimately prevent infectious, immunologic, and allergic diseases.”

You can read Dr. Paul’s amendment HERE.

*

Note to readers: Please click the share buttons above or below. Follow us on Instagram, @globalresearch_crg and Twitter at @crglobalization. Feel free to repost and share widely Global Research articles.  

Featured image is from Children’s Health Defense
Articles by: Sen. Rand Paul

Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]

www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the copyright owner.

For media inquiries: [email protected]